SynthesisPsycho-oncology2014
Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.
Synthesis in Psycho-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 445 papers, 23 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The effect of better model counselling with model over sexual problems of women with breast cancer
Analisi Dei Marcatori di Stress Ossidativo in Pazienti Affetti da Tumore Della Mammella, Sottoposte a Radioterapia Postoperatoria e Psicoterapia Con Elementi di Musicoterapia
Psychobiotics Ameliorate Anxiety and Depression Status in Patients Under Chemotherapy for Gastrointestinal Malignancies
Who cites it
445 citing papers in PubMed, 23 syntheses or guidelines pooled it, 882 citations in OpenAlex.
- The effects of virtual reality on anxiety and depression in cancer patients: a systematic review with meta-analysis.BMC public health · 2026Pooled it
- Perioperative Depressive Symptoms in Surgical Cancer Patients: a Systematic Review and Meta-analysis.Annals of surgical oncology · 2026Pooled it
- Depression increases cancer mortality by 23-83%: a meta-analysis of 65 studies across five major cancer types.GeroScience · 2026Pooled it
- Prevalence of depression in patients with advanced cancer receiving palliative care: a meta-analysis of self-report instruments.Frontiers in psychiatry · 2026Pooled it
- Effects of different exercise interventions on depression and anxiety in cancer survivors: a systematic review and Bayesian network meta-analysis of randomized controlled trials.Frontiers in oncology · 2026Pooled it
- The application of esketamine in cancer-related depressive states: attention from mechanisms to clinical translation.Frontiers in psychiatry · 2026Pooled it
- Exploring Communication Dynamics Between Patients and Healthcare Providers in Oncology: A Systematic Review.Health expectations : an international journal of public participation in health care and health policy · 2025Pooled it
- Understanding the Trajectory of Depressive Symptoms in Newly Diagnosed High-Grade Glioma Patients-A Meta-Analysis.Psycho-oncology · 2025Pooled it
- Impact of Depression on Mortality in Patients with Pancreatic Cancer: A Systematic Review.Current oncology (Toronto, Ont.) · 2025Pooled it
- A Systematic Review of Trajectories of Clinically Relevant Distress Amongst Adults with Cancer: Course and Predictors.Journal of clinical psychology in medical settings · 2025Pooled it
- Acceptance and commitment therapy processes and their association with distress in cancer: a systematic review and meta-analysis.Health psychology review · 2024Pooled it
- Prevalence and associated factors of depression in postmenopausal women: a systematic review and meta-analysis.BMC psychiatry · 2024Pooled it
- A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis.JNCI cancer spectrum · 2024Pooled it
- The prevalence of anxiety symptoms/disorders in cancer patients: a meta-analysis.Frontiers in psychiatry · 2024Pooled it
- Suicide Mortality Risk among Patients with Lung Cancer-A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2023Pooled it
- Pooled it
- Cognitive behavioral therapy for anxiety and depression in cancer survivors: a meta-analysis.Scientific reports · 2022Pooled it
- The prevalence of depression and anxiety in patients with cancer in Iran: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Pooled it
- Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review.European journal of cancer care · 2022Pooled it
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis.Clinical and molecular hepatology · 2022Pooled it
385 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe aimed to investigate the prevalence of depression in cancer patients assessed by diagnostic interviews and self-report instruments, and to study differences in prevalence between type of instrument, type of cancer and treatment phase.
methodsA literature search was conducted in four databases to select studies on the prevalence of depression among adult cancer patients during or after treatment. A total of 211 studies met the inclusion criteria. Pooled mean prevalence of depression was calculated using Comprehensive Meta-Analysis.
resultsHospital Anxiety and Depression Scale-depression subscale (HADS-D) ≥ 8, HADS-D ≥11, Center for Epidemiologic Studies ≥ 16, and (semi-)structured diagnostic interviews were used to define depression in 66, 53, 35 and 49 studies, respectively. Respective mean prevalence of depression was 17% (95% CI = 16-19%), 8% (95% CI = 7-9%), 24% (95% CI = 21-26%), and 13% (95% CI = 11-15%) (p < 0.001). Prevalence of depression ranged from 3% in patients with lung cancer to 31% in patients with cancer of the digestive tract, on the basis of diagnostic interviews. Prevalence of depression was highest during treatment 14% (95% CI = 11-17%), measured by diagnostic interviews, and 27% (95% CI = 25-30%), measured by self-report instruments. In the first year after diagnosis, prevalence of depression measured with diagnostic interviews and self-report instruments were 9% (95% CI = 7-11%) and 21% (95% CI = 19-24%), respectively, and they were 8% (95% CI = 5-12%) and 15% (95% CI = 13-17%) ≥ 1 year after diagnosis.
conclusionsPooled mean prevalence of depression in cancer patients ranged from 8% to 24% and differed by the type of instrument, type of cancer and treatment phase. Future prospective studies should disentangle whether differences in prevalence of depression are caused by differences in the type of instrument, type of cancer or treatment phase. © 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.